Rodman & Renshaw Reiterates Buy on Cassava Sciences, Maintains $107 Price Target
Portfolio Pulse from Benzinga Newsdesk
Rodman & Renshaw analyst Elemer Piros has reiterated a Buy rating on Cassava Sciences (NASDAQ:SAVA) and maintained a price target of $107.
August 08, 2024 | 6:29 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Rodman & Renshaw analyst Elemer Piros has reiterated a Buy rating on Cassava Sciences and maintained a price target of $107.
The reiteration of a Buy rating and a high price target of $107 by a reputable analyst is likely to positively impact investor sentiment and drive short-term price appreciation for Cassava Sciences.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100